Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
5.51M
-
Shares change
-
+449K
-
Total reported value, excl. options
-
$38.2M
-
Value change
-
+$3.12M
-
Number of buys
-
14
-
Number of sells
-
-7
-
Price
-
$6.94
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2017
35 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2017.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.51M shares
of 15M outstanding shares and own 36.79% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (1.39M shares), DIMENSIONAL FUND ADVISORS LP (864K shares), Stonepine Capital Management, LLC (740K shares), BlackRock Inc. (419K shares), VANGUARD GROUP INC (297K shares), NEW YORK STATE COMMON RETIREMENT FUND (294K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (294K shares), RENAISSANCE TECHNOLOGIES LLC (270K shares), JW Asset Management, LLC (264K shares), and ACADIAN ASSET MANAGEMENT LLC (130K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.